Yahoo
NYSE - Delayed Quote USD

Abrdn Healthcare Investors (HQH)

20.93 +0.15 (+0.72%)
At close: October 28 at 4:00:03 PM EDT
21.20 +0.27 (+1.29%)
Pre-Market: 7:50:19 AM EDT
Trade HQH on Coinbase
Chart Range Bar
Loading chart for HQH
  • Previous Close 20.78
  • Open 20.70
  • Bid 20.20 x 10000
  • Ask 22.60 x 10000
  • Day's Range 20.68 - 21.00
  • 52 Week Range 17.14 - 24.85
  • Volume 119,952
  • Avg. Volume 180,701
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.75
  • PE Ratio (TTM) 4.68
  • EPS (TTM) 4.47
  • Earnings Date --
  • Forward Dividend & Yield 2.47 (11.80%)
  • Ex-Dividend Date Aug 24, 2026
  • 1y Target Est --

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

--

Full Time Employees

September 30

Fiscal Year Ends

Asset Management

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/28/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HQH
20.88%
S&P 500 (^GSPC)
13.13%

1-Year Return

HQH
20.50%
S&P 500 (^GSPC)
12.38%

3-Year Return

HQH
112.02%
S&P 500 (^GSPC)
88.08%

5-Year Return

HQH
37.26%
S&P 500 (^GSPC)
68.48%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4,561.32%

  • Return on Assets (ttm)

    -0.35%

  • Return on Equity (ttm)

    24.21%

  • Revenue (ttm)

    5.54M

  • Net Income Avi to Common (ttm)

    252.77M

  • Diluted EPS (ttm)

    4.47

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: